| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| Accounting Fees | 3,750 | 3,750 | 0 |
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| Investment in Applied StemCell Inc | 52,500 | 52,500 |
| NexBio | 571,170 | 571,170 |
| investment - credit suisse 0151 | 0 | 0 |
| investment - credit suisse 5116 | 0 | 0 |
| Investment - UBS 6770 | 532,394 | 471,776 |
| investment - UBS 6773 | 673,344 | 652,163 |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| other expenses | 5,684 | 5,684 | 0 |
| Description | Revenue And Expenses Per Books | Net Investment Income | Adjusted Net Income |
|---|---|---|---|
| CAPITAL GAIN DISTRIBUTIONS | 8,749 | 8,749 | 8,749 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| Investment Fees | 15,490 | 15,490 | 0 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| FOREIGN TAXES | 522 | 522 | 0 | |
| Federal Tax | 2,191 | 2,191 | 0 |